Your browser doesn't support javascript.
Gas Exchange Impairment During COVID-19 Recovery.
Gochicoa-Rangel, Laura; Hernández-Morales, Aloisia Paloma; Salles-Rojas, Antonio; Madrid-Mejía, Wilmer; Guzmán-Valderrábano, Carlos; González-Molina, Amaury; Salas-Escamilla, Isabel; Durán-Cuellar, Adela; Silva-Cerón, Mónica; Hernández-Morales, Víctor; Reyes-García, Alejandro; Alvarado-Amador, Irlanda; Lozano-Martínez, Luis; Enright, Paul; Pensado-Piedra, Lya Edith; Torre-Bouscoulet, Luis.
  • Gochicoa-Rangel L; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico. drgochis@gmail.com.
  • Hernández-Morales AP; Department of Image, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Salles-Rojas A; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Madrid-Mejía W; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Guzmán-Valderrábano C; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • González-Molina A; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Salas-Escamilla I; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Durán-Cuellar A; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Silva-Cerón M; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Hernández-Morales V; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Reyes-García A; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Alvarado-Amador I; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Lozano-Martínez L; Department of Respiratory Physiology, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Enright P; Pulmonary Function Test Laboratory, Institute for Development and Innovation in Respiratory Physiology, Mexico City, Mexico.
  • Pensado-Piedra LE; Department of Image, National Institute of Respiratory Diseases "Ismael Cosío Villegas," Mexico City, Mexico.
  • Torre-Bouscoulet L; Pulmonary Function Test Laboratory, Institute for Development and Innovation in Respiratory Physiology, Mexico City, Mexico.
Respir Care ; 66(10): 1610-1617, 2021 10.
Article in English | MEDLINE | ID: covidwho-1381426
ABSTRACT

BACKGROUND:

Persistent impairment of pulmonary function and exercise capacity has been known to last for months or even years in the survivors who recovered from other coronavirus pneumonia. Some reports showed that subjects with coronavirus disease 2019 pneumonia after being discharged could have several sequelae, but there are few studies on gas exchange and exercise capacity complications in these subjects.

AIMS:

To describe residual gas exchange abnormalities during recovery from coronavirus disease 2019 pneumonia.

METHODS:

In an observational study, ∼90 d after onset of disease, we scheduled almost 200 subjects for an out-patient visit with pulmonary function testing and computed tomography of the lungs. Lung mechanics by using body plethysmography, gas exchange with diffusing lung capacity for carbon monoxide determined by the single-breath technique (DLCOsb) and diffusing lung capacity for nitric oxide determined by the single-breath technique (DLNOsb), and exercise ability by using the 6-min walk test (6MWT) were measured in the subjects. The results were compared between those who required invasive mechanical ventilation and those who did not.

RESULTS:

A total of 171 subjects were included, the majority (96%) had signs of residual pneumonia (such as an excess of high attenuation areas) on computed tomography of the lungs. The DLCOSB results were below the lower limit of the normal range in 29.2% of the subjects; during the 6MWT, 67% experienced oxygen desaturation ([Formula see text]) > 4%; and, in 81 (47%), the dropped below 88%. Subjects who required invasive mechanical ventilation (49.7%) were more likely to have lower lung volumes, more gas exchange abnormality, less exercise capacity and more radiologic abnormality.

CONCLUSIONS:

Subjects who recovered from severe COVID-19 pneumonia continued to have abnormal lung function and abnormal radiologic findings.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Respir Care Year: 2021 Document Type: Article Affiliation country: Respcare.09114

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Respir Care Year: 2021 Document Type: Article Affiliation country: Respcare.09114